Effects of cisplatin-5-fluorouracil combination therapy on oxidative stress, DNA damage, mitochondrial apoptosis, and death receptor signalling in retinal pigment epithelium cells

References

• Almhanna K, Hoffe S, Strosberg J, et al. Concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil (5-FU) and cisplatin for locally advanced resectable esophageal cancer. J Gastrointest Oncol 2015;6:39–44.
   PubMed Web of Science ®Google Scholar
• Wang C, Song D-J, Xu Z-L, et al. A network meta-analysis of the short-term efficacy of five chemotherapy regimens based on cisplatin and fluorouracil for esophagogastric junctional adenocarcinoma. Exp Mol Med 2017;49:e383.
   PubMed Web of Science ®Google Scholar
• Gou H, Gu L, Shang B, et al. Protective effect of Bu-Zhong-Yi-Qi decoction, the water extract of Chinese traditional herbal medicine, on 5-fluorouracil-induced intestinal mucositis in mice. Hum Exp Toxicol 2016;35:1243–1251.
   PubMed Web of Science ®Google Scholar
• Kart A, Cigremis Y, Karaman M, et al. Caffeic acid phenethyl ester (CAPE) ameliorates cisplatin-induced hepatotoxicity in rabbit. Exp Toxicol Pathol 2010;62:45–52.
   PubMed Web of Science ®Google Scholar
• Al‐Tweigeri T, Nabholtz JM, Mackey JR. Ocular toxicity and cancer chemotherapy: a review. Cancer 1996;78:1359–1373.
   PubMed Web of Science ®Google Scholar
• Hazin R, Abuzetun JY, Daoud YJ, et al. Ocular complications of cancer therapy: a primer for the ophthalmologist treating cancer patients. Curr Opin Ophthalmol 2009;20:308–317.
   PubMed Web of Science ®Google Scholar
• Becher R, Schütt P, Osieka R, et al. Peripheral neuropathy and ophthalmologic toxicity after treatment with cis-dichlorodiaminoplatinum II. J Cancer Res Clin Oncol 1980;96:219–222.
   PubMed Web of Science ®Google Scholar
• Bonadonna G, Brusamolino E, Valagussa P, et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 1976;294:405–410.
   PubMed Web of Science ®Google Scholar
• Cohen RJ, Cuneo RA, Cruciger MP, et al. Transient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with cisplatinum, vinblastine, and bleomycin. J Clin Oncol 1983;1:392–393.
   PubMed Web of Science ®Google Scholar
• Crispino S, Pizzocaro G, Solero C, et al. Transient left homonymous hemianopsia during treatment of testicular carcinoma with cisplatinum, vinblastine, and bleomycin. Chemioterapia 1984;3:337–339.
   PubMedGoogle Scholar
• Wilding G, Caruso R, Lawrence T, et al. Retinal toxicity after high-dose cisplatin therapy. J Clin Oncol 1985;3:1683–1689.
   PubMed Web of Science ®Google Scholar
• Schmid KE, Kornek GV, Scheithauer W, et al. Update on ocular complications of systemic cancer chemotherapy. Surv Ophthalmol 2006;51:19–40.
   PubMed Web of Science ®Google Scholar
• Maino DM, Tran S, Mehta F. Side effects of chemotherapeutic oculo-toxic agents: a review. Clin Eye Vis Care 2000;12:113–117.
   PubMedGoogle Scholar
• Delval L, Klastersky J. Optic neuropathy in cancer patients. Report of a case possibly related to 5 fluorouracil toxicity and review of the literature. J Neurooncol 2002;60:165–169.
   PubMed Web of Science ®Google Scholar
• Majji AB, de Juan E. Jr, Retinal pigment epithelial autotransplantation: morphological changes in retina and choroid. Graefes Arch Clin Exp Ophthalmol 2000;238:779–791.
   PubMed Web of Science ®Google Scholar
• Zhang X, Hughes BA. KCNQ and KCNE potassium channel subunit expression in bovine retinal pigment epithelium. Exp Eye Res 2013;116:424–432.
   PubMed Web of Science ®Google Scholar
• Juuti-Uusitalo K, Nieminen M, Treumer F, et al. Effects of cytokine activation and oxidative stress on the function of the human embryonic stem cell–derived retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2015;56:6265–6274.
   PubMed Web of Science ®Google Scholar
• Boya P, Esteban-Martínez L, Serrano-Puebla A, et al. Autophagy in the eye: development, degeneration, and aging. Prog Retin Eye Res 2016;55:206–245.
   PubMed Web of Science ®Google Scholar
• Roehlecke C, Valtink M, Frenzel A, et al. Stress responses of human retinal pigment epithelial cells to glyoxal. Graefes Arch Clin Exp Ophthalmol 2016;254:2361–2372.
   PubMed Web of Science ®Google Scholar
• Bennis A, Jacoline B, Moerland PD, et al. Comparative gene expression study and pathway analysis of the human iris-and the retinal pigment epithelium. PLoS One 2017;12:e0182983.
   PubMed Web of Science ®Google Scholar
• Langevin S, Chang JS, Chang S. Serous retinopathy associated with cisplatin treatment. Retinal Cases & Brief Reports 2017; doi: 10.1097/ICB.0000000000000573
   PubMedGoogle Scholar
• Mitra A, Edmunds MR, Walji N, et al. Reversible branch retinal artery occlusion following intravenous cisplatin chemotherapy for cervical carcinoma. Int Ophthalmol 2011;31:429–432.
   PubMedGoogle Scholar
• Yazici A, Sogutlu-Sari E, Yay A, et al. The protective effect of selenium in cisplatin-related retinotoxicity. Cutan Ocul Toxicol 2014;33:327–32.
   PubMed Web of Science ®Google Scholar
• Penha FM, Rodrigues EB, Maia M, et al. Retinal and ocular toxicity in ocular application of drugs and chemicals–part II: retinal toxicity of current and new drugs. Ophthalmic Res 2010;44:205–224.
   PubMed Web of Science ®Google Scholar
• Kivilcim M, Kazi AA, Peyman GA, et al. Retinal toxicity of intravitreal 5-fluorouracil in silicone-filled rabbit eyes. J Coll Physicians Surg Pak 2006;16:351–354.
   PubMedGoogle Scholar
• van Hennik MB, van der Vijgh WJ, Klein I, et al. Comparative pharmacokinetics of cisplatin and three analogues in mice and humans. Cancer Res 1987;47:6297–6301.
   PubMed Web of Science ®Google Scholar
• Andreadis C, Vahtsevanos K, Sidiras T, et al. 5-Fluorouracil and cisplatin in the treatment of advanced oral cancer. Oral Oncol 2003;39:380–385.
   PubMed Web of Science ®Google Scholar
• Focaccetti C, Bruno A, Magnani E, et al. Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ROS production in endothelial cells and cardiomyocytes. PLoS One 2015;10:e0115686.
   PubMed Web of Science ®Google Scholar
• Doganlar ZB. Evaluation of the selective anticancer potential and the genetic mechanisms of the induction of apoptosis by walnut milk in human breast and prostate cancer cells. Biomed Res 2016;27:268–278.
   Google Scholar
• Jinesh GG, Taoka R, Zhang Q, et al. Novel PKC-ζ to p47 phox interaction is necessary for transformation from blebbishields. Sci Rep 2016;6:23965.
   PubMed Web of Science ®Google Scholar
• Schumacker PT. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 2006;10:175–176.
   PubMed Web of Science ®Google Scholar
• Gomathy N, Sumantran VN, Shabna A, et al. Tolerance of ARPE 19 cells to organophosphorus pesticide chlorpyrifos is limited to concentration and time of exposure. Pestic Biochem Physiol 2015;117:24–30.
   PubMed Web of Science ®Google Scholar
• Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 2014;740:364–378.
   PubMed Web of Science ®Google Scholar
• Ceilley RI. Mechanisms of action of topical 5-fluorouracil: review and implications for the treatment of dermatological disorders. J Dermatolog Treat 2012;23:83–89.
   PubMed Web of Science ®Google Scholar
• Doganlar O, Doganlar BZ. Responses of antioxidant enzymes and heat shock proteins in Drosophila to treatment with a pesticide mixture. Arch Biol Sci 2015;67:869–876.
   Google Scholar
• Piano A, Valbonesi P, Fabbri E. Expression of cytoprotective proteins, heat shock protein 70and metallothioneins, in tissues of Ostrea edulis exposed to heat andheavy metals. Cell Stress Chaperones 2004;9:134–142.
   PubMed Web of Science ®Google Scholar
• Zarate J, Bradley TM. Heat shock proteins are not sensitive indicators of hatchery stress in salmon. Aquaculture 2003;223:175–187.
   Web of Science ®Google Scholar
• Singh MP, Reddy MK, Mathur N, et al. Induction of hsp70, hsp60, hsp83 and hsp26 and oxidative stress markers in benzene, toluene and xylene exposed Drosophila melanogaster: role of ROS generation. Toxicol Appl Pharmacol 2009;235:226–243.
   PubMed Web of Science ®Google Scholar
• Ghanem L, Steinman R. A proapoptotic function of p21 in differentiating granulocytes. Leuk Res 2005;29:1315–1323.
   PubMed Web of Science ®Google Scholar
• Harper JW, Adami GR, Wei N, et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75:805–816.
   PubMed Web of Science ®Google Scholar
• Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994;78:67–74.
   PubMed Web of Science ®Google Scholar
• Cakmak H, Gokmen E, Bozkurt G, et al. Effects of Sunitinib and Bevacizumab on VEGF and miRNA levels on corneal neovascularization. Cutan Ocul Toxicol 2018;37:191–195.
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Zeiher AM. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res 2000;87:434–439.
   PubMed Web of Science ®Google Scholar
• Midena E, Lazzarini D, Catania AG, et al. Cytostatic and cytotoxic effects of 5-fluorouracil on human corneal epithelial cells and keratocytes. Cornea 2013;32:338–344.
   PubMed Web of Science ®Google Scholar
• Di Lisi D, Madonna R, Zito C, et al. Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond. Int J Cardiol 2017;227:11–17.
   PubMed Web of Science ®Google Scholar
• Pizzocaro G, Nicolai N, Milani A. Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results. Eur Urol 2009;55:546–551.
   PubMed Web of Science ®Google Scholar
• Igaki H, Kato H, Ando N, et al. A randomized trial of postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for clinical stage II/III squamous cell carcinoma of the thoracic esophagus (JCOG 9907). J Clin Oncol 2008;26(155_suppl):4510.
   Web of Science ®Google Scholar
• Simó R, Villarroel M, Corraliza L, et al. The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier—implications for the pathogenesis of diabetic retinopathy. J Biomed Biotechnol 2010;2010:190724.
   PubMedGoogle Scholar
• Sparrrow JR, Hicks D, Hamel CP. The retinal pigment epithelium in health and disease. Curr Mol Med 2010;10:802–823.
   PubMed Web of Science ®Google Scholar
• Veal EA, Toone WM, Jones N, et al. Distinct roles for glutathione S-transferases in the oxidative stress response in Schizosaccharomyces pombe. J Biol Chem 2002;277:35523–35531.
   PubMed Web of Science ®Google Scholar
• Townsend DM, Tew KD. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 2003;22:7369–7375.
   PubMed Web of Science ®Google Scholar
• Yousef M, Saad A, El-Shennawy L. Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats. Food Chem Toxicol 2009;47:1176–1183.
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Tsuji Y, Kaai K, et al. Toxicity against gastric cancer cells by combined treatment with 5-fluorouracil and mitomycin c: implication in oxidative stress. Cancer Chemother Pharmacol 2010;66:517–526.
   PubMed Web of Science ®Google Scholar
• Polk A, Nielsen DL, Vistisen K, et al. A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity. BMC Pharmacol Toxicol 2014;15:47.
   PubMed Web of Science ®Google Scholar
• Xiao T, Choudhary S, Zhang W, et al. Possible involvement of oxidative stress in cisplatin-induced apoptosis in LLC-PK1 cells. J Toxicol Environ Health Part A 2003;66:469–479.
   PubMed Web of Science ®Google Scholar
• Nielsen F, Mikkelsen BB, Nielsen JB, et al. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 1997;43:1209–1214.
   PubMed Web of Science ®Google Scholar
• Kehrer JP. The Haber-Weiss reaction and mechanisms of toxicity. Toxicology 2000;149:43–50.
   PubMed Web of Science ®Google Scholar
• Drummond JT, Genschel J, Wolf E, et al. DHFR/MSH3 amplification in methotrexate-resistant cells alters the hMutSα/hMutSβ ratio and reduces the efficiency of base–base mismatch repair. Proc Natl Acad Sci U S A 1997;94:10144–10149.
   PubMed Web of Science ®Google Scholar
• Ding X, Mohd A, Huang Z, et al. MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibition. Br J Cancer 2009;101:269–277.
   PubMed Web of Science ®Google Scholar
• Rich T, Allen RL, Wyllie AH. Defying death after DNA damage. Nature 2000;407:777–783.
   PubMed Web of Science ®Google Scholar
• Yoon M-K, Mitrea DM, Ou L, et al. Cell cycle regulation by the intrinsically disordered proteins p21 and p27. Biochem Soc Trans 2012;40:981–988.
   PubMed Web of Science ®Google Scholar
• Price PM, Safirstein RL, Megyesi J. Protection of renal cells from cisplatin toxicity by cell cycle inhibitors. Am J Physiol Renal Physiol 2004;286:F378–F384.
   PubMed Web of Science ®Google Scholar
• Ren Y-G, Wagner KW, Knee DA, et al. Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle. Mol Biol Cell 2004;15:5064–5074.
   PubMed Web of Science ®Google Scholar
• LeBlanc H, Ashkenazi A. Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ 2003;10:66–75.
   PubMed Web of Science ®Google Scholar